Top Markets
Coin of the day
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporation

NVIV
株式のランク #39771
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm,... InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
株価
$0.26
最終同期: 2024-03-11
時価総額
$356.29K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 InVivo Therapeutics Holdings Corporation (NVIV)

カテゴリー

InVivo Therapeutics Holdings Corporation(NVIV)のEPS
2026 時点のEPS TTM: 0
InVivo Therapeutics Holdings Corporationの最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
InVivo Therapeutics Holdings CorporationのEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS